These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18161933)

  • 21. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve.
    Ishikawa T; Kubota T; Horigome R; Kimura N; Honda H; Iwanaga A; Seki K; Honma T; Yoshida T
    Hepatol Res; 2014 Oct; 44(11):1056-61. PubMed ID: 23941627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study.
    Caturelli E; Siena DA; Fusilli S; Villani MR; Schiavone G; Nardella M; Balzano S; Florio F
    Radiology; 2000 Apr; 215(1):123-8. PubMed ID: 10751477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of transcatheter chemoembolization of the internal thoracic artery in patients with hepatocellular carcinoma.
    Fan QS; Huo XK; Wang MQ; Liu FY; Duan F; Wang ZJ; Song P
    Chin Med J (Engl); 2011 May; 124(9):1374-80. PubMed ID: 21740751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors related to acute upper gastrointestinal bleeding after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma].
    Wu JX; Huang JF; Yu ZJ; Meng XY; Li DG; Lu HM
    Ai Zheng; 2002 Aug; 21(8):881-4. PubMed ID: 12478898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
    Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
    AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extrahepatic collateral arteries are involved in the blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization].
    Li Q; Yang RJ; Zhu X; Zhu LZ; Wang MQ; Duan F
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):613-7. PubMed ID: 24314221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.
    Lobo L; Yakoub D; Picado O; Ripat C; Pendola F; Sharma R; ElTawil R; Kwon D; Venkat S; Portelance L; Yechieli R
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1580-1588. PubMed ID: 27586657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemolipiodolization with or without embolization in transcatheter arterial chemoembolization combined with radiofrequency ablation for hepatocellular carcinoma-propensity score matching analysis.
    Shi F; Zhang L; Li S; Lin CJ; Shen LJ; Li CF; Jie M; Li ZW; Wu PH
    Oncotarget; 2016 May; 7(21):31311-21. PubMed ID: 27121318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
    Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
    World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical value of transcatheter arterial chemoembolization therapy for hepatocellular carcinoma with blood supply from right adrenal artery].
    Liao GS; Liu X; Luo XP; He MJ; Yang W
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):835-841. PubMed ID: 30616318
    [No Abstract]   [Full Text] [Related]  

  • 32. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
    Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
    Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined transcatheter arterial chemoembolization and beta-ultrasound guided portal vein embolization in the treatment of hepatocellular carcinoma.
    Mao G; Yu Z; Zhang Y; Cheng J
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):391-3. PubMed ID: 12408773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
    Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
    Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trans-arterial p53-gene-embolization with gelatin sponge microparticles for hepatocellular carcinoma with BCLC stage B: single-center experience.
    Liu Y; Zhang Y; Bautista D; Tang S; Zhou J; Li C; Zhao G
    Cell Biochem Biophys; 2015 Jan; 71(1):99-104. PubMed ID: 25323562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergency embolization in the treatment of ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization.
    Sun JH; Wang LG; Bao HW; Lou JL; Cai LX; Wu C; Chen LM; Zheng SS
    Hepatogastroenterology; 2010; 57(99-100):616-9. PubMed ID: 20698237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
    Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
    AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of combination therapy of chemoembolization and radiofrequency ablation with different time intervals for hepatocellular carcinoma patients.
    Feng YM; Wang X; Wang L; Ma XW; Wu H; Bu HR; Xie XY; Qi JN; Zhu Q
    Surg Oncol; 2017 Sep; 26(3):236-241. PubMed ID: 28807242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.